warfarin + YM178
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Overactive Bladder
Conditions
Overactive Bladder, Pharmacokinetics
Trial Timeline
Sep 1, 2008 → Dec 1, 2008
NCT ID
NCT00856570About warfarin + YM178
warfarin + YM178 is a phase 1 stage product being developed by Astellas Pharma for Overactive Bladder. The current trial status is completed. This product is registered under clinical trial identifier NCT00856570. Target conditions include Overactive Bladder, Pharmacokinetics.
What happened to similar drugs?
20 of 20 similar drugs in Overactive Bladder were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00856570 | Phase 1 | Completed |
Competing Products
20 competing products in Overactive Bladder